Business

Transfer of Lock-in Shares

Transfer of Lock-in Shares.

articleCellbxhealth PlcDecember 12, 20173/company/cellbxhealth-plc/news/transfer-of-lock-in-shares
Transfer of Lock-in Shares

About this update from Cellbxhealth Plc

[{"type":"text","content":"\n \nRNS Number : 0247Z Angle PLC 12 December 2017  \n\n\n\n\n\nFor immediate release\n\n\n 12 December 2017\n\n\n\n\n \nANGLE plc (\"the Company\")\n \nTransfer of Lock-in Shares\n \nANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, announces that further to the announcement of 16 November 2017, finnCap and WG Partners have given their written consent to allow Covington to transfer the 4,579,169 Ordinary Shares subject to the Covington Lock-in Deed (the \"Lock-in Shares\") to Dermot Keane, an existing significant shareholder in the Company.\n \nDermot Keane has entered into an equivalent agreement to the Covington Lock-in Deed, pursuant to which he has agreed to not dispose of any interest in the Lock-in Shares for a period of 18 months from 16 November 2017, save for: prior written consent being received from finnCap and WG Partners; or to a connected person of Dermot Keane; or in acceptance of any takeover offer; or where required by law or pursuant to an intervening court order.\n \nThe transfer of the Lock-in Shares was agreed between Covington and Dermot Keane as an off-market transaction at a price of 36 pence per Lock-in Share.\n  \n \nANGLE Founder and Chief Executive, Andrew Newland, commented:\n\"We are pleased that one of our significant shareholders has further demonstrated his long term support for ANGLE and agreed terms with Covington for the Lock-in Shares assisting them to address the near-term redemption obligations of the Covington Fund II.\"\n \n \n \nCapitalised terms not otherwise defined in this announcement shall have the same meaning ascribed to such terms in the announcement entitled \"Acquisition and Fundraising\" released on 5 October 2017 unless the context requires otherwise.\n \n \nFor further information ANGLE:\n \n\n\n\n\nANGLE plc\n\n\n+44 (0) 1483 343434\n\n\n\n\nAndrew Newland, Chief Executive\nIan Griffiths, Finance Director\n \n\n\n\n\n\n\n\nfinnCap Ltd (NOMAD and Joint Broker)\nCorporate Finance - Adrian Hargrave, Simon Hicks, Kate Bannatyne\nCorporate Broking - Alice Lane, Nikita Jain \n \n\n\n+44 (0) 20 7220 0500\n\n\n\n\nWG Partners (Joint Broker)\nNigel Barnes, Nigel Birks, Andrew Craig, Chris Lee \n \n\n\n+44 (0) 203 705 9330\n \n \n\n\n\n\nFTI Consulting\nSimon Con...

More updates from Cellbxhealth Plc